Krabbe Disease Archives - Forge Biologics

Labcorp and Forge Biologics Announce Strategic AAV Gene Therapy Development and Manufacturing Collaboration

Forge Biologics Receives Qualified Person (QP) Declaration to Manufacture AAV Gene Therapies to Support European Clinical Programs

Forge Biologics Reports Positive FBX-101 Clinical Updates for Patients with Krabbe Disease at WORLDSymposium

Designing for the Future of Cell and Gene Therapy Facilities

<img width="600" height="338" alt="" decoding="async" data-srcset="https://www.forgebiologics.com/wp-content/uploads/2021/04/NerveCells_ColinBehrens_Pixabay.jpg 600w, https://www.forgebiologics.com/wp-content/uploads/2021/04/NerveCells_ColinBehrens_Pixabay-300x169.jpg 300w" data-src="https://www.forgebiologics.com/wp-content/uploads/2021/04/NerveCells_ColinBehrens_Pixabay.jpg" data-sizes="(max-width: 600px) 100vw, 600px" class="attachment-scaled size-scaled wp-post-image lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="600" height="338" src="https://www.forgebiologics.com/wp-content/uploads/2021/04/NerveCells_ColinBehrens_Pixabay.jpg" class="attachment-scaled size-scaled wp-post-image" alt="" decoding="async" srcset="https://www.forgebiologics.com/wp-content/uploads/2021/04/NerveCells_ColinBehrens_Pixabay.jpg 600w, https://www.forgebiologics.com/wp-content/uploads/2021/04/NerveCells_ColinBehrens_Pixabay-300x169.jpg 300w" sizes="(max-width: 600px) 100vw, 600px" />

44 Thriving Biotech Startups (2021)

<img width="600" height="338" alt="" decoding="async" data-srcset="https://www.forgebiologics.com/wp-content/uploads/2021/04/NerveCells_ColinBehrens_Pixabay.jpg 600w, https://www.forgebiologics.com/wp-content/uploads/2021/04/NerveCells_ColinBehrens_Pixabay-300x169.jpg 300w" data-src="https://www.forgebiologics.com/wp-content/uploads/2021/04/NerveCells_ColinBehrens_Pixabay.jpg" data-sizes="(max-width: 600px) 100vw, 600px" class="attachment-scaled size-scaled wp-post-image lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="600" height="338" src="https://www.forgebiologics.com/wp-content/uploads/2021/04/NerveCells_ColinBehrens_Pixabay.jpg" class="attachment-scaled size-scaled wp-post-image" alt="" decoding="async" srcset="https://www.forgebiologics.com/wp-content/uploads/2021/04/NerveCells_ColinBehrens_Pixabay.jpg 600w, https://www.forgebiologics.com/wp-content/uploads/2021/04/NerveCells_ColinBehrens_Pixabay-300x169.jpg 300w" sizes="(max-width: 600px) 100vw, 600px" />

Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord

<img width="600" height="338" alt="" decoding="async" data-srcset="https://www.forgebiologics.com/wp-content/uploads/2021/04/NerveCells_ColinBehrens_Pixabay.jpg 600w, https://www.forgebiologics.com/wp-content/uploads/2021/04/NerveCells_ColinBehrens_Pixabay-300x169.jpg 300w" data-src="https://www.forgebiologics.com/wp-content/uploads/2021/04/NerveCells_ColinBehrens_Pixabay.jpg" data-sizes="(max-width: 600px) 100vw, 600px" class="attachment-scaled size-scaled wp-post-image lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="600" height="338" src="https://www.forgebiologics.com/wp-content/uploads/2021/04/NerveCells_ColinBehrens_Pixabay.jpg" class="attachment-scaled size-scaled wp-post-image" alt="" decoding="async" srcset="https://www.forgebiologics.com/wp-content/uploads/2021/04/NerveCells_ColinBehrens_Pixabay.jpg 600w, https://www.forgebiologics.com/wp-content/uploads/2021/04/NerveCells_ColinBehrens_Pixabay-300x169.jpg 300w" sizes="(max-width: 600px) 100vw, 600px" />

EMA Orphan Drug Designation for Forge Biologics’ gene therapy for Krabbe disease

FDA Fast Track, ODD, and RPDD Designations for FBX-101 Gene Therapy for Patients with Krabbe Disease

FDA Clearance of Investigational New Drug for Patients with Krabbe Disease

I agree to the Cookie Notice and Privacy Policy

I agree